Plasma-derived C1 esterase inhibitor pharmacokinetics and safety in patients with hereditary angioedema

BACKGROUND: Over 40 years of use demonstrates that complement 1 esterase inhibitor (C1-INH) concentrate is effective and well tolerated for acute edema attacks and prophylaxis in patients with hereditary angioedema. OCTA-C1-INH is a new stable, virus-inactivated, nanofiltrated concentrate of C1-INH...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez-Saguer, Inmaculada, Bork, Konrad, Latysheva, Tatiana, Zabrodska, Liudmyla, Chopyak, Valentyna, Nenasheva, Natalia, Totolyan, Areg, Krivenchuk, Vitaliy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684372/
https://www.ncbi.nlm.nih.gov/pubmed/38033485
http://dx.doi.org/10.1016/j.jacig.2023.100178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684372/
https://www.ncbi.nlm.nih.gov/pubmed/38033485
http://dx.doi.org/10.1016/j.jacig.2023.100178

Ejemplares similares